Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: M6030H73N9

Pharmacology

Action Mechanism of Action Reference
CROSS-LINKING AGENT CD276 antigen cross-linking agent Other PubMed
Primary Target
B7-H3 (CD276)

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Carcinoma, Squamous Cell 2 D002294 ClinicalTrials
Prostatic Neoplasms, Castration-Resistant 2 D064129 ClinicalTrials
Melanoma 1 D008545 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 1353485-38-7
ChEMBL CHEMBL3545373
FDA SRS M6030H73N9
Guide to Pharmacology 9589